Jo Parkes: Subcutaneous Immunotherapy – Can we actually deliver it?
Jo Parkes, Lead Clinical Pharmacist – Cancer Services and Advanced Clinical Practice at Worcestershire Acute Hospitals NHS Trust, shared a post on LinkedIn by The Immunobuddies Podcast, adding:
“The Immunobuddies Podcast Episode 152: Subcutaneous Immunotherapy – Can we actually deliver it?
We’re back…. This week we take a deep-dive into what it really takes to deliver subcutaneous immunotherapy into clinical practice.
Planning IV-to-SC switch?
The BOPA (The British Oncology Pharmacy Association) Immunotherapy Specialist Advisory Group has developed a comprehensive toolkit to support implementation. Practical. Straightforward. Designed for the real world.
You can find this resource on the BOPA website.
Huge shout out to all the oncology teams working tirelessly behind the scenes to make this transition a reality, your efforts are driving meaningful change for patients.”
Quoting The Immunobuddies Podcast‘s post:
“New Episode Out Now!
Subcutaneous Immunotherapy – What are the logisitics?
In Episode 152, the Immunobuddies Ricky Frazer and Dr Anna Olsson-Brown are back with Jo Parkes and Dr Vasiliki Michalarea to tackle the real-world logistics of rolling out subcutaneous immunotherapy in clinical practice.
- How do we build pathways?
- What are the pharmacy and dosing challenges?
- Can subcutaneous immunotherapy improve access and patient experience?
This is the how-to episode for anyone working in IO, oncology pharmacy, or service delivery!
More posts featuring Jo Parkes.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023